BirchBioMed’s FS2 topical cream leverages KynA’s properties to enhance ECM remodeling and reduce inflammation directly at the site of application. FS2 offers a non-invasive option for patients suffering from various dermatological disorders, providing targeted, localized therapy with the potential to improve skin health and appearance without systemic side effects.
Health Canada granted regulatory approval of FS2 topical cream as a natural health product and authorized its distribution in Canada as a non-prescription product for the treatment of scars, including mature keloids.